Senior Oncology Launch Manager - Desmoid Territory

Immunome, Inc.; New York (NY); On-site; USD 210,000 - 235,000; Full time

Benefits offered by this job

Medical, dental, vision insurance

401(k) with employer match

Paid time off

Paid holidays

Parental leave

Job summary

Immunome, Inc. is seeking a Senior Oncology Account Manager in the United States to drive territory sales for varegacestat in desmoid tumors.

You will build relationships with physicians and office staff, execute a local brand strategy, and support patient access and education in a compliant, patient-centric manner. You will work with Market Development, Marketing, Market Access, and Medical Affairs to deliver insights and value-based messaging, aiming to establish Immunome as a trusted partner

Qualifications

• Bachelor's degree required.
• 7+ years of pharmaceutical or biotech sales experience in oncology or rare disease.
• Proven track record of meeting or exceeding sales targets.
• Strong communication and relationship-building skills.

Responsibilities

• Achieve or exceed territory sales goals for varegacestat.
• Develop and execute territory business plans identifying priority accounts and call plans.
• Deliver compliant, value-based selling messages to healthcare providers.
• Maintain understanding of desmoid tumor treatment landscape and payer dynamics.
• Report territory activity and results using approved CRM tools.

Skills

Communication

Presentation skills

Relationship-building

CRM systems

Self-motivation

Independent worker

Education

Bachelor's degree

Tools

CRM systems

Job description

Immunome, Inc. is seeking a Senior Oncology Account Manager in the United States to drive territory sales for varegacestat in desmoid tumors.

You will build relationships with physicians and office staff, execute a local brand strategy, and support patient access and education in a compliant, patient-centric manner. You will work with Market Development, Marketing, Market Access, and Medical Affairs to deliver insights and value-based messaging, aiming to establish Immunome as a trusted partner